DYAI
Dyadic International, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.52
+3.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 16.07x
- P/E 2028E
- —
- P/S forward
- 2.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -8.73x
- Price / sales
- 6.00x
- Price / cash flow
- -2.81x
Enterprise value
- Enterprise value
- $22.8M
- EV / sales
- 6.56x
- EV / EBITDA
- -3.17x
- EV / EBIT
- -3.07x
- Market cap
- $20.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026